Typical and atypical imaging findings of intrahepatic cholangiocarcinoma using gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging

Journal of Computer Assisted Tomography

Volumn 36, Issue 6, 2012, Pages 704-709

  Kim, So Hee ^a   Lee, Chang Hee ^a,b   Kim, Baek Hui ^a   Kim, Wan Bae ^b   Yeom, Suk Keu ^c   Kim, Kyeong Ah ^a   Park, Cheol Min ^a  

^a Department of Radiology ^*  (South Korea)

^b Korea University College of Medicine   (South Korea)

^c Korea University   (South Korea)

Author keywords

Cholangiocarcinoma; Gadoxetic acid; Gd EOB DTPA; Liver; MRI

Indexed keywords

DEFECTS; GADOLINIUM; IMAGE ENHANCEMENT;

CHOLANGIOCARCINOMA; DIETHYLENETRIAMINE PENTA-ACETIC ACIDS; DOMINANT PHASIS; GADOLINIA; GADOXETIC ACID; GD-EOB-DTPA; HEPATOBILIARY; INTENSITY RATIO; PERIPHERAL DEFECTS; SIGNAL INTENSITIES;

MAGNETIC RESONANCE IMAGING;

GADOXETIC ACID;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CLASSIC MASS FORMING INTRAHEPATIC CHOLANGIOCARCINOMA; CLINICAL ARTICLE; CLINICAL FEATURE; CONTRAST ENHANCEMENT; DIFFERENTIAL DIAGNOSIS; DIFFUSION WEIGHTED IMAGING; FEMALE; HEPATIC ARTERY; HEPATOBILIARY PHASE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERVASCULAR MASS FORMING INTRAHEPATIC CHOLANGIOCARCINOMA; IMAGE ANALYSIS; LIVER PARENCHYMA; MALE; MORPHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

EID: 84870929986     PISSN: 03638715     EISSN: 15323145     Source Type: Journal    
DOI: 10.1097/RCT.0b013e3182706562     Document Type: Article

References (18)

1. Ros PR, Buck JL, Goodman ZD, et al. Intrahepatic cholangiocarcinoma: radiologic-pathologic correlation. Radiology. 1988;167:689-693.
2. Park J, Kim MH, Kim KP, et al. Natural history and prognostic factors of advanced cholangiocarcinoma without surgery, chemotherapy, or radiotherapy: a large-scale observational study. Gut Liver. 2009;3:298-305.
3. Liver Cancer Study Group of Japan. Classification of Primary Liver Cancer. Tokyo, Japan: Kanehara; 1997.
4. Lim JH. Cholangiocarcinoma: morphologic classification according to growth pattern and imaging findings. AJR Am J Roentgenol. 2003;181:819-827.
5. Maetani Y, Itoh K, Watanabe C, et al. MR imaging of intrahepatic cholangiocarcinoma with pathologic correlation. AJR Am J Roentgenol. 2001;176:1499-1507.
6. Kim SJ, Lee JM, Han JK, et al. Peripheral mass-forming cholangiocarcinoma in cirrhotic liver. AJR Am J Roentgenol. 2007;189:1428-1434.
7. Chen L-D, Xu H-X, Xie X-Y, et al. Enhancement patterns of intrahepatic cholangiocarcinoma: comparison between contrast-enhanced ultrasound and contrast-enhanced CT. Br J Radiol. 2008;81:881-889.
8. Vilana R, Forner A, Bianchi L, et al. Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast-enhanced ultrasound. Hepatology. 2010;51:2020-2029.
9. Rimola J, Forner A, Reig M, et al. Cholangiocarcinoma in cirrhosis: absence of contrast washout in delayed phase by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma. Hepatology. 2009;50:791-798.
10. Kim SA, Lee JM, Lee KB, et al. Intrahepatic mass-forming cholangiocarcinomas: enhancement patterns at multiphasic CT, with special emphasis on arterial enhancement patternVcorrelation with clinicopathologic findings. Radiology. 2011;260:148-157.
11. Khan SA, Davidson BR, Goldin R, et al. Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut. 2002;41:1-9.
12. Chung YE, Kim MJ, Park YN, et al. Varying appearances of cholangiocarcinoma: radiologic pathologic correlation. Radiographics. 2009;29:683-700.
13. Nanashima A, Sumida Y, Abo T, et al. Relationship between pattern of tumor enhancement and clinicopathologic characteristics in intrahepatic cholangiocarcinoma. J Surg Oncol. 2008;98:535-539.
14. Asayama Y, Yoshimitsu K, Irie H, et al. Delayed-phase dynamic CT enhancement as a prognostic factor for mass-forming intrahepatic cholangiocarcinoma. Radiology. 2006;238:150-155.
15. Valls C, Guma A, Puig I, et al. Intrahepatic peripheral cholangiocarcinoma: CT evaluation. Abdom Imaging. 2000;25:490-496.
16. Lee CH, Kim KA, Lee J, et al. Using low tube voltage (80kVp) quadruple phase liver CT for the detection of hepatocellular carcinoma: two-year experience and comparison with Gd-EOB-DTPA enhanced liver MRI. Eur J Radiol. 2012;81:605-611.
17. Lee SA, Lee CH, Jung WY, et al. Paradoxical high signal intensity of hepatocellular carcinoma in the hepatobiliary phase of Gd-EOB-DTPA enhanced MRI: initial experience. Magn Reson Imaging. 2011;29:83-90.
18. Tangkijvanich P, Thong-ngam D, Theamboonlers A, et al. Diagnostic role of serum interleukin 6 and CA 19-9 in patients with cholangiocarcinoma. Hepatogastroenterology. 2004;51:15-19.